In order to view this page properly, you need to have Javascript enabled.
Current Issue
Archives
Upcoming Issues
Advisory Board
Contribute
Meet the Staff
Features
News
Products
Features
News
Products
Features
News
Products
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News
New Products
Cell-Based Technology
Chemistry/Pharmacology
HTS Automation
Informatics
Instrumentation
Resources
Glossary
Associations
Calendar
Webcasts
White Papers
Job Search
NEWSLETTERS
|
WHITE PAPERS
|
SUBSCRIBE
|
ADVERTISE
|
CONTACT US
|
ABOUT US
Today is:
News
Life Science News
Pharma/Biotech News
Drug Discovery News
Drug Development News
Genomics and Proteomics News
Legal/Regulatory News
Business/Financial News
Supplier News
SITE SPONSORS
Advertise with Us
Browse Drug Development News:
GSK Withdrawing Cancer Drug Application
British drugmaker GlaxoSmithKline PLC says it's withdrawing its application for U.S. approval of a drug to prevent prostate cancer.
continue
Immunovaccine Licenses Technology to Pfizer
Immunovaccine Inc. said that Pfizer Inc., the world's largest drugmaker, is licensing its technology for use in vaccines for cattle.
continue
Raptor Drug Meets Key Goals
Raptor Pharmaceutical Corp. said its developing treatment for the genetic disorder nephropathic cystinosis met key goals in a midstage study.
continue
Advisory Panel Recommends Merck Fertility Drug
Drug developer Merck & Co. said a European advisory committee recommended approval for the company's fertility drug Elonva.
continue
FDA Panel Backs Spiriva Handihaler
Federal health experts brushed off lingering safety questions about a popular inhaler drug and suggested it carry bolder benefit claims.
continue
Matthew Perrone
Experimental Drug Might Restore Spinal Cord Function
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.
continue
Pharmasset to Continue Hepatitis C Trial
Pharmasset Inc. will continue enrolling patients in a clinical trial of RG7128, a drug that is designed to treat the liver disease hepatitis C.
continue
Matthew Perrone
Bevacizumab Effective Against Biliary-Tract Cancers
Bevacizumab given in addition to the combined chemotherapy regimen of gemcitabine and oxaliplatin (GEMOX-B) is well tolerated and shows promising antitumour activity in patients with advanced biliary-tract cancers.
continue
Abbott Initiates Trial For Bioabsorbable Stent
Abbott announced three-year data demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries
continue
Activity Test Improves Prediction of Cardiovascular Events
Aterovax SA, announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease over a five-year period.
continue
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
>> More
GSK To Eliminate 4,000 Jobs
AstraZeneca To Layoff 8,000 Workers
Pfizer Pares, Refocuses Research After Wyeth Buy
Understanding Fragile X Syndrome
Ataluren for Nonsense Mutation Genetic Disorders
Validating Neurogenesis as a Therapeutic Target for Depression
Exenatide Once-Weekly Superior to Twice-Daily Injection
Victoza Gains FDA Approval
HIV Researchers Reveal Integrase Structure
Thermo Fisher Scientific Acquires Finnzymes
© 2010
Advantage Business Media
Privacy Policy
|
Terms & Conditions
|
Advertise with Us